Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ekso Bionics | EKSO | Nov 25, 2024 | 0.69 | -0.07 |
El Paso Pref | EP-C | Nov 25, 2024 | 48.48 | +0.12 |
El Pollo Loco | LOCO | Nov 25, 2024 | 12.76 | +3.74 |
Elanco Animal Health | ELAN | Nov 25, 2024 | 13.39 | +0.22 |
Elastic | ESTC | Nov 25, 2024 | 111.48 | +3.19 |
Elbit Systems | ESLT | Nov 25, 2024 | 253.11 | +1.20 |
Eldorado Gold | EGO | Nov 25, 2024 | 15.69 | -5.25 |
Electra Battery Materials | ELBM | Nov 25, 2024 | 0.50 | +1.85 |
Electro-Sensors | ELSE | Nov 25, 2024 | 4.34 | +2.72 |
electroCore | ECOR | Nov 25, 2024 | 11.35 | +1.25 |
Electromed | ELMD | Nov 25, 2024 | 30.26 | +1.58 |
Electronic Arts | EA | Nov 25, 2024 | 164.14 | -1.52 |
Electrovaya | ELVA | Nov 25, 2024 | 2.72 | +15.25 |
Eledon Pharmaceuticals | ELDN | Nov 25, 2024 | 4.01 | 0.00 |
Element Solutions | ESI | Nov 25, 2024 | 29.33 | +1.00 |
Elevai Labs | ELAB | Nov 25, 2024 | 0.02 | -20.90 |
Elevance Health | ELV | Nov 25, 2024 | 407.60 | +1.25 |
Elevation Oncology | ELEV | Nov 25, 2024 | 0.61 | +0.81 |
Eli Lilly | LLY | Nov 25, 2024 | 755.00 | +0.93 |
Elicio Therapeutics | ELTX | Nov 25, 2024 | 5.00 | +1.42 |
Eliem Therapeutics | ELYM | Nov 25, 2024 | 5.11 | 0.00 |
Ellington Financial | EFC-B | Nov 25, 2024 | 23.20 | +0.43 |
Ellington Financial | EFC | Nov 25, 2024 | 12.48 | -0.32 |
Ellington Financial A Pref | EFC-A | Nov 25, 2024 | 25.30 | +0.04 |
Ellington Financial D Pref | EFC-D | Nov 25, 2024 | 23.34 | +2.07 |
Ellington Financial E Pref | EFC-E | Nov 25, 2024 | 25.47 | +0.08 |
Ellington Financial Pref | EFC-C | Nov 25, 2024 | 25.00 | -0.99 |
Ellington Residential Mortgage REIT | EARN | Nov 25, 2024 | 6.73 | -0.44 |
Ellomay Capital | ELLO | Nov 25, 2024 | 16.49 | +2.93 |
Ellsworth Growth | ECF | Nov 25, 2024 | 9.85 | +1.34 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.